AstraZeneca's market cap is currently $230.00B. The company's EPS TTM is $2.269; its P/E ratio is 32.96; and it has a dividend yield of 1.95%. AstraZeneca is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $1.11. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 54.07B	$ 45.81B	$ 44.35B	$ 37.42B	$ 26.62B
Gross Profit	$ 43.87B	$ 37.77B	$ 31.96B	$ 24.98B	$ 21.32B
Operating Income	$ 10.00B	$ 8.19B	$ 3.76B	$ 1.06B	$ 5.16B
EBITDA	$ 17.12B	$ 13.42B	$ 8.65B	$ 4.67B	$ 7.58B
Net Income	$ 7.04B	$ 5.96B	$ 3.29B	$ 112.00M	$ 3.20B
Balance Sheet
Cash & Short-Term Investments	$ 5.65B	$ 5.86B	$ 6.41B	$ 6.40B	$ 7.99B
Total Assets	$ 104.03B	$ 101.12B	$ 96.48B	$ 105.36B	$ 66.73B
Total Debt	$ 30.11B	$ 28.62B	$ 29.23B	$ 30.78B	$ 20.38B
Net Debt	$ 24.63B	$ 22.78B	$ 23.07B	$ 24.45B	$ 12.55B
Total Liabilities	$ 63.16B	$ 61.95B	$ 59.42B	$ 66.08B	$ 51.09B
Stockholders' Equity	$ 40.79B	$ 39.14B	$ 37.04B	$ 39.27B	$ 15.62B
Cash Flow
Free Cash Flow	$ 7.28B	$ 6.57B	$ 7.24B	$ 3.76B	$ 2.19B
Operating Cash Flow	$ 11.86B	$ 10.35B	$ 9.81B	$ 5.96B	$ 4.80B
Investing Cash Flow	$ -7.98B	$ -4.06B	$ -2.96B	$ -11.06B	$ -285.00M
Financing Cash Flow	$ -4.00B	$ -6.57B	$ -6.82B	$ 3.65B	$ -2.20B

Currency in USD

AstraZeneca Earnings and Revenue History

Income Statement >

AstraZeneca Debt to Assets

Balance Sheet >

AstraZeneca Cash Flow

Cash Flow >

AstraZeneca Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing